Healio Minute Podcast, Dermatology Edition: Top Headlines - Week of November 13, 2023

ByJessica Jones

In this edition, dermatologists ‘uniquely positioned’ to aid human trafficking victims; FDA approves Cosentyx for hidradenitis suppurativa and more.

Read the full coverage here:

Dermatologists ‘uniquely positioned’ to recognize, aid human trafficking victims

FDA approves Cosentyx as first IL-17A inhibitor for hidradenitis suppurativa

FDA approves Stelara biosimilar for treatment of psoriasis, multiple inflammatory diseases

RECELL system efficacious in vitiligo repigmentation

Isotretinoin efficacious in seborrheic dermatitis treatment

References:

Elbuluk N. Optimizing melanocyte cell transplant procedure for treatment of vitiligo. Presented at: American Society for Dermatologic Surgery Annual Meeting; Nov 1-5, 2023; Chicago.

Kourosh S. The role of dermatologic surgeons in advocating for those affected by human trafficking. Presented at: American Society for Dermatologic Surgery Annual Meeting; Nov 1-5, 2023; Chicago.

Press Release

Tan MG, et al. Isotretinoin for the management of moderate to severe seborrheic dermatitis. Presented at: American Society for Dermatologic Surgery Annual Meeting; Nov 1-5, 2023; Chicago.

Published by:

Sources/Disclosures

Collapse

Disclosures: Please see each study for relevant financial disclosures.

Read more

Healio Minute Podcast, Dermatology Edition: Top Headlines - Week of November 13, 2023

Healio Minute: Dermatology Edition

Related Content